Actively Recruiting
Evaluation of the Indigo Aspiration System for Removing Blood Clots in Patients with Lower Extremity Acute Limb Ischemia
Led by Penumbra Inc. · Updated on 2026-08-31
300
Participants Needed
45
Research Sites
30 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are collecting and evaluating clinical evidence to assess the safety and performance of the Indigo21 Aspiration System in patients with lower extremity acute limb ischemia LE ALI. This observational study focuses on patients diagnosed with acute arterial occlusions in the lower limbs. The goal is to support understanding of how the Indigo Aspiration System functions in this population. Participants receive treatment using the Indigo Aspiration System, a device designed for mechanical aspiration thrombectomy to remove thrombus. The study monitors patients who undergo first-line treatment with this system using Computer Assisted Vacuum Thrombectomy CAVT aspiration tubing. Patients may be re-enrolled if they experience a new acute occlusion in the opposite limb more than 30 days after the initial procedure. During the study, participants are assessed for outcomes such as target limb salvage rate 30 days after the procedure, technical success immediately after the procedure, primary patency at 30 days, and rates of device-related major bleeding, distal embolization, serious adverse events, and mortality at 30 and 180 days post-procedure. The study includes follow-up evaluations to monitor safety and effectiveness over time, with participation lasting until the study ends in 2029.
CONDITIONS
Brief Title
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Research Team
M
Marina Mello
J
Jemymah Allen
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here